Shopping Cart 0
Cart Subtotal
USD 0

IntegraGen SA (ALINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, genomic research tools and solutions to microbiologic researchers. It also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis and bioinformatics analysis of sequence data services, among others. IntegraGen develops miR-31-3p, a microRNA biomarker for metastatic colorectal and lung cancer. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics and agriculture. It caters to patients, clinicians and researchers. The company has operations in France and the US. IntegraGen is headquartered in Paris, France.

IntegraGen SA (ALINT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IntegraGen SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9

IntegraGen SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

IntegraGen SA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

AP-HP Enters into Research Agreement with IntegraGen 11

IntegraGen Enters into Agreement with Klinikum der Ludwig-Maximilians-Universitat Munchen 12

IntegraGen Enters into Agreement with Hopital Europeen Georges Pompidou 13

Licensing Agreements 14

IntegraGen Enters into Licensing Agreement with Inserm 14

Equity Offering 15

IntegraGen Raises USD4 Million in Private Placement of Shares 15

IntegraGen Completes Private Placement Of Shares For USD 2.5 Million 16

IntegraGen SA-Key Competitors 17

IntegraGen SA-Key Employees 18

IntegraGen SA-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Financial Announcements 20

Sep 20, 2018: Integragen announces 17% increase in sales revenue and a 57% increase in operating profit for the first half of 2018 20

Jul 09, 2018: IntegraGen Reports 17% Revenue Growth During First Half of 2018 22

Apr 13, 2018: IntegraGen Reports 2017 Annual Results 23

Jan 09, 2018: IntegraGen Reports 2017 revenue and cash position 25

Sep 29, 2017: IntegraGen Reports Financial Results for 1st Half of 2017 26

Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017 28

Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%) 29

Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016 32

Legal and Regulatory 33

Apr 23, 2018: IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

IntegraGen SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IntegraGen SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

IntegraGen SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IntegraGen SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IntegraGen SA, Deals By Therapy Area, 2012 to YTD 2018 8

IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9

IntegraGen SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

AP-HP Enters into Research Agreement with IntegraGen 11

IntegraGen Enters into Agreement with Klinikum der Ludwig-Maximilians-Universitat Munchen 12

IntegraGen Enters into Agreement with Hopital Europeen Georges Pompidou 13

IntegraGen Enters into Licensing Agreement with Inserm 14

IntegraGen Raises USD4 Million in Private Placement of Shares 15

IntegraGen Completes Private Placement Of Shares For USD 2.5 Million 16

IntegraGen SA, Key Competitors 17

IntegraGen SA, Key Employees 18

IntegraGen SA, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

IntegraGen SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.